newsfilter
← Latest News
GlobeNewswire·

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May

  • Foghorn Therapeutics Inc. (NASDAQ: FHTX) announced management participation in three upcoming investor events in May 2026.
  • One-on-one meetings will occur at the H.C. Wainwright 4th Annual Bioconnect Investor Conference at Nasdaq on May 19, 2026.
  • President and CEO Adrian Gottschalk will present at the 2026 Stifel Virtual Targeted Oncology Forum on May 20, 2026, at 11:00 a.m. EDT, with additional one-on-one meetings.
  • Adrian Gottschalk will present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA on May 26, 2026, at 8:30 a.m. EDT.
  • The company focuses on oncology using its Gene Traffic Control® platform to target genetically determined dependencies within the chromatin regulatory system.
  • Karin Hellsvik is listed as the contact person for media inquiries.